1 Min Read
July 12 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd :
* China Food and Drug Administration has granted approval of phase I-III clinical trials of Birociclib Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.